0001225208-12-001302.txt : 20120112 0001225208-12-001302.hdr.sgml : 20120112 20120112170027 ACCESSION NUMBER: 0001225208-12-001302 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120112 FILED AS OF DATE: 20120112 DATE AS OF CHANGE: 20120112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abate Thomas M CENTRAL INDEX KEY: 0001346974 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 12524700 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0304 4 2012-01-12 0001099800 Edwards Lifesciences Corp EW 0001346974 Abate Thomas M ONE EDWARDS WAY IRVINE CA 92614 1 CVP, CFO Common Stock 2012-01-12 4 M 0 10000.0000 13.0050 A 57925.0000 D Common Stock 2012-01-12 4 S 0 10000.0000 73.9100 D 47925.0000 D Employee Stock Option (Right to Acquire) 13.0050 2012-01-12 4 M 0 10000.0000 0.0000 D 2003-05-08 2012-05-07 Common Stock 10000.0000 30000.0000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2011. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This transaction was executed in multiple trades at prices ranging from $73.41 to $74.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Denise E. Botticelli, Attorney-in-Fact 2012-01-12